The development of targeted therapies has revolutionized cancer treatment, and Crizotinib is a prime example of such progress. As a potent inhibitor of anaplastic lymphoma kinase (ALK) and ROS1, it has significantly improved outcomes for patients with specific types of non-small cell lung cancer (NSCLC). Behind the efficacy of drugs like Crizotinib lies a complex synthesis pathway, where specific chemical intermediates play a crucial, often unsung, role. One such vital component is N-Boc-4-Hydroxypiperidine, identified by CAS number 109384-19-2.

N-Boc-4-Hydroxypiperidine, a protected form of 4-hydroxypiperidine, is an indispensable building block in the multi-step synthesis of Crizotinib. Its structure, featuring a piperidine ring with a hydroxyl group at the 4-position and a tert-butoxycarbonyl (Boc) protecting group, allows for precise chemical modifications that are essential for constructing the final Crizotinib molecule. The presence of the Boc group ensures selective reactions at other parts of the molecule, preventing unwanted side reactions involving the piperidine nitrogen, while the hydroxyl group serves as a handle for further functionalization.

For pharmaceutical companies engaged in the production of Crizotinib or related research, sourcing high-quality N-Boc-4-Hydroxypiperidine is a critical operational requirement. The purity and consistency of this intermediate directly impact the yield and quality of the final Active Pharmaceutical Ingredient (API). Therefore, identifying a reliable manufacturer and supplier is paramount. Buyers often seek out chemical providers who can guarantee a purity of ≥98.0% and offer a stable supply chain, particularly from regions known for their expertise in fine chemical manufacturing, such as China.

The ability to purchase N-Boc-4-Hydroxypiperidine in quantities suitable for both laboratory research and large-scale industrial production is a key consideration. Manufacturers that can offer flexible packaging and delivery options, along with comprehensive technical support and documentation (like COAs and SDS), are highly valued. This ensures that researchers and production teams have all the necessary information and materials to proceed efficiently with their synthesis processes.

In summary, N-Boc-4-Hydroxypiperidine is a foundational intermediate that underpins the successful synthesis of Crizotinib. Its strategic importance in pharmaceutical chemistry underscores the need for careful supplier selection. By partnering with a reputable manufacturer, companies can ensure access to this crucial chemical, thereby facilitating the continued development and availability of life-saving cancer treatments. If your R&D requires this key intermediate, we are a leading supplier ready to meet your needs.